Fujifilm Fights Ebola And Gives You Good Skin
17 Dec 2014 · 2 min

1:32
A YouTube video (Dec 17, 2014) by Zaur AI describing how Fujifilm shifted from photography toward healthcare. The video explains Fujifilm’s proactive R&D-driven diversification: initial consumer-health products (supplements, vitamins, cosmetics), later pharmaceutical expansion via acquisition, and development of a drug candidate for Ebola. It cites Fujifilm’s 2014 annual report estimating photography-related revenues at about 15% of total, and argues this strategic pivot helped avoid a "Kodak moment."
Questions this video answers
Approximately 15% (per Fujifilm's 2014 annual report, as cited in the transcript).










